Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Prostate Cancer Clinical Trials in Minneapolis | 147 Studies

Clinical Trials Prostate CancerMinneapolis

Prostate Cancer Clinical Trials in Minneapolis

Find 147 clinical trials for prostate cancer near Minneapolis, Minnesota. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Minneapolis

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 41-60 of 147 trials

Active not recruitingTo Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringThis phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active…NCT04597359·Fairbanks, Alaska and 352 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerBone metastases and associated pain are a major cause of morbidity and mortality in castration-resistant prostate cancer (CRPC).NCT01522443·Scottsdale, Arizona and 81 others

RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsThis phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from…NCT03866382·Birmingham, Alabama and 581 others

RecruitingTesting Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialThis randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of…NCT07200830·Anchorage, Alaska and 141 others

Active not recruitingAntiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryThis randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation therapy to see how well it works compared with antiandrogen therapy and radiation therapy…NCT03070886·Mobile, Alabama and 312 others

RecruitingStudy of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate CancerThe goal of this clinical trial is to study the combination of SX-682 plus enzalutamide in men with metastatic castration resistant prostate cancer (mCRPC) who have failed prior…NCT06228053·Los Angeles, California and 5 others

WithdrawnAbemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerThis research is studying two experimental drugs, abemaciclib and atezolizumab, alone and in combination with each other, to learn about the safety and effectiveness of these…NCT04272645·Boston, Massachusetts and 3 others

TerminatedJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsAvelumab in combination with talazoparib will be investigated in patients with locally advanced (primary or recurrent) or metastatic solid tumors, including non-small cell lung…NCT03330405·Fayetteville, Arkansas and 65 others

CompletedObservational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management.NCT02380274·Homewood, Alabama and 147 others

CompletedCASCARA: Castration Sensitive Carboplatin, Cabazitaxel and AbirateroneThis is a phase II clinical trial in patients with metastatic castration sensitive prostate cancer.NCT03934840·Phoenix, Arizona and 7 others

Active not recruitingA Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer ImagingThe primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of…NCT03445559·Palo Alto, California and 10 others

RecruitingStudy of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)This study is a first-in-human, Phase 1, open-label, multicenter study to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy…NCT05519449·Birmingham, Alabama and 37 others

RecruitingTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingThis phase III trial tests two questions by two separate comparisons of therapies.NCT04423211·Anchorage, Alaska and 340 others

CompletedA Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerThe purpose of this study was to determine the efficacy and safety of oral enzalutamide compared to bicalutamide in castrate men with metastatic prostate cancer who have…NCT01288911·Homewood, Alabama and 87 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 435 others

Active not recruitingA Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyThis randomized, placebo-controlled phase III trial is evaluating the benefit of rucaparib and enzalutamide combination therapy versus enzalutamide alone for the treatment of men…NCT04455750·Anchorage, Alaska and 413 others

Active not recruitingStudy of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer…NCT05348577·Yuma, Arizona and 216 others

CompletedChemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaVA Cooperative Study #553 is designed to prospectively evaluate the efficacy of early adjuvant chemotherapy using docetaxel and prednisone added to the standard of care for…NCT00132301·Birmingham, Alabama and 33 others

TerminatedFigitumumab Combined With Pegvisomant For Advanced Solid TumorsThis is a Phase 1 study investigating the safety and tolerability of Figitumumab plus Pegvisomant for treatment of advanced solid tumors.NCT00976508·Minneapolis, Minnesota and 4 others

CompletedA Study of Enzalutamide and LY3023414 in Men With Prostate CancerThe main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY3023414 in combination with enzalutamide in men with prostate cancer.NCT02407054·Homewood, Alabama and 35 others

PreviousPage 3 of 8Next

Other Conditions in Minneapolis

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma